Table 3.
Peri-COVID-19 hospitalizations and deaths during at-risk time in the primary analytical cohort and subgroup analyses
| COLUMN ONE | BNT162b2 | Ad26.COV2.S | P |
|---|---|---|---|
| All pairs | |||
| COVID-19 diagnoses, n | 75 | 83 | |
| Hospitalizations, n (%)a | 36 (48.0%) | 44 (53.0%) | 0.53 |
| Deaths, n (%)b | 5 (6.7%) | 3 (3.6%) | 0.38 |
| Pairs with no prior COVID-19c | |||
| COVID-19 diagnoses, n | 75 | 83 | |
| Hospitalizations, n (%) | 36 (48.0%) | 44 (53.0%) | 0.53 |
| Deaths, n (%) | 5 (6.7%) | 3 (3.6%) | 0.38 |
| Completer pairsd | |||
| COVID-19 diagnoses, n | 68 | 81 | |
| Hospitalizations, n (%) | 29 (42.7%) | 44 (54.3%) | 0.16 |
| Deaths, n (%) | 5 (7.4%) | 3 (3.7%) | 0.33 |
| Completer pairs with no prior COVID-19c,d | |||
| COVID-19 diagnoses, n | 68 | 81 | |
| Hospitalizations, n (%) | 29 (42.7%) | 44 (54.3%) | 0.16 |
| Deaths, n (%) | 5 (7.4%) | 3 (3.7%) | 0.33 |
a
Peri–COVID-19 hospitalizations defined as any hospitalization occurring between 7 days before and 21 days after COVID-19 diagnosis; percentages represent the percent of patients with a hospitalization event.
b
Peri–COVID-19 death defined as any death occurring between COVID-19 diagnosis and documented recovery; percentages represent the percent of patients who died.
c
Refers to COVID-19 before index date (date of first vaccination).
d
Matched pairs in which the BNT162b2 member completed a two-dose series.